Growth-factor signaling
Tesamorelin
Tesamorelin, synthetic growth-hormone-releasing factor (GRF 1-44) analogue
- 5 mg — TSM5
- 10 mg — TSM10
- 20 mg — TSM20
Tesamorelin + Ipamorelin
Tesamorelin + Ipamorelin
- SKU family:
- TSM13+IP3
- Format:
- Single sealed vial
Tesamorelin + Ipamorelin research blend. Component literature is available; this exact combination is not validated by those studies.
$237.00 per single vial before volume savings
AvailableFulfilment timing confirmed after review
1
Choose 1–10 single vials. For more, switch to 10-vial kits: 10, 20, 30, 40 vials and so on, up to 100 per request.
1 vial · 0% volume savings$237.00
Add 1 more vial of this strength to save 5%.
1 vial
0% off
$237.00*
2–3 vials
5% off
$225.15*
4–5 vials
10% off
$213.30*
6–7 vials
15% off
$201.45*
8–9 vials
20% off
$189.60*
10+ vials
25% off
$177.75*
Same product and strength only. Above 10 vials, choose whole ten-vial kits (20, 30, 40 and so on). *Approximate price per vial; totals round per line. A valid referral discount applies afterward. Final availability and terms are confirmed before processing.
Typically available within 5–10 business days. Fulfillment timing will be confirmed before processing your research-order request.
Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.
No published batch record for this material yet.
Overview
This listing combines Tesamorelin + Ipamorelin. Researchers study the components in distinct experimental systems, summarized below. The references provide context for those individual materials and are not evidence that the catalog blend has been tested.
A laboratory research blend of Tesamorelin and Ipamorelin. Nominal component fills, in that order: 13 mg + 3 mg (16 mg total) per vial. Select the exact strength and SKU for your research protocol. Catalog listing and supplier availability do not establish on-hand stock; availability and fulfillment timing are confirmed before a Research Order Request is processed. Nominal fill is a label specification, not a batch assay result. Consult the exact published lot document for any reported analytical result. For laboratory research use only; not for human, veterinary, clinical or diagnostic use.
Research
What researchers study — the questions and models in the cited literature.
- Tesamorelin: GHRH-axis clinical research
- Ipamorelin: secretagogue-receptor experiments
Evidence & research models
Component evidence only
Separate component studies; no primary study of this exact blend verified in this review.
What this evidence does not establish
The linked papers study individual components, not this exact mixture or component ratio. They do not establish compatibility, stability, synergy, combined biological activity or safety of the blend.
Primary research sources
- Tesamorelin endocrine and metabolic endpoints — original trial (PubMed, opens in a new tab)
- Ipamorelin receptor pharmacology — original study (PubMed, opens in a new tab)
Literature describes the materials and models used by those investigators. It is not a certificate of analysis for current inventory or evidence that this catalog lot was used in a study. For laboratory research only; not for human or veterinary use.
Storage and laboratory handling
Use the storage and handling conditions in the approved documentation for the exact supplied lot. If those conditions have not been supplied, request confirmation before accepting delivery. Packaging visualizations do not establish storage conditions or stability.
Documentation
No published batch record exists for this material yet. We do not state identity, purity, mass, sterility, or endotoxin status without a report for the exact lot.
FAQ
Related products
Growth-factor signaling
CJC-1295 with DAC
- 5 mg — CD5
- 10 mg — CD10
Growth-factor signaling
CJC-1295 without DAC
- 5 mg — CND5
- 10 mg — CND10
Tesamorelin + Ipamorelin · 13 mg + 3 mg (16 mg total)
$237.00